References
- Conroy, S., & Hill, D. (2014). Failure to identify or effectively manage prescription opioid dependence acted as a gateway to heroin use—Methadone maintenance treatment followed by high-dose transfer to buprenorphine /naloxone and recovery in a surgical patient. BMJ Case Reports. doi:10.1136/bcr-2014-207458
- Cooper, R. J. (2013). “I can’t be an addict. I am.” Over-the-counter medicine abuse: A qualitative study. British Medical Journal Open, 3, e002913. doi:10.1136/bmjopen-2013-002913
- Fingleton, N., Matheson, C., Watson, M., & Duncan, E. (2014). Non-prescription medicine misuse and dependence in the UK: A general population survey. Health Services Research and Pharmacy Practice. Aberdeen, April 3–4.
- Foley, M., Harris, R., Rich, E., Rapca, A., Bergin, M., Norman, I., & Van Hout, M. C. (2015). The availability of over-the-counter codeine medicines across the European Union. Public Health. doi:10.1016/j.puhe.2015.06.014
- Hard, B. (2014). Management of opioid Painkiller dependence in primary care: Ongoing recovery with buprenorphine/naloxone. BMJ Case Reports. doi:10.1136/bcr-2014-207308
- MacFadyen, L., Eadie, D., & McGowan, T. (2001). Community pharmacists’ experience of over-the-counter medicine misuse in Scotland. The Journal of the Royal Society for the Promotion of Health, 121(3), 185–192.
- Marr, E., & Hill, D. (2015). Optimising service provision for prescribed opioid analgesic dependence. Heroin Addiction and Related Clinical Problems, 17(5), 13–18.
- Matheson, C., Bond, C., & Pitcairn, J. (2002). Misuse of over-the-counter medicines from community pharmacies: A population survey of Scottish Pharmacies. Pharmaceutical Journal, 269, 66–68.
- Matheson, C., Bond, C. M., & Mollison, J. (1999). Factors associated with community pharmacists’ involvement in services for drug misusers. Addiction, 94(9), 1349–1359.
- Matheson, C., Bond, C. M., & Tinelli, M. (2007). Community pharmacy harm reduction services for drug misusers: National service delivery and professional attitude development over a decade in Scotland. Journal of Public Health, 29(4), 350–357.
- National Institution for Health and Care Excellence [NICE] (2012) Overuse of Painkillers Can Make Headaches Worse. [online] NICE. Available at http://www.nice.org.uk/news/article/overuse-of-painkillers-can-make-headaches-worse ( accessed November 2014).
- Pates, R., McBride, A. J., Li, S., & Ramadan, R. (2002). Misuse of over-the-counter Medicines: A survey of community pharmacies in a South Wales health authority. Pharmaceutical Journal, 268, 179–182.
- Reed, K., Bond, A., Witton, J., Cornish, R., Hickman, M., & Strang, J. (2011). The Changing Use of Prescribed Benzodiazepines and Z-Drugs, & of Over-The-Counter Codeine-Containing Products in England: A Structured Review of Published English & International Evidence & Available Data to Inform Consideration of the Extent of Dependence. London: The National Addiction Centre, Kings College London.
- Sherazi, B. A., Mahmood, K. T., Amin, F., Zaka, M., Riaz, M., & Javed, A. (2012). Prevalence and measure of self-medication: A review. Journal of Pharmaceutical Sciences and Research, 4(3), 1774–1778.
- University of Aberdeen (2014) Ground-breaking research shows frequency of addiction to over-the-counter medicines. Available at http://www.abdn.ac.uk/news/6992/Date ( accessed November 2014)
- Van Hout, M. C., Delargy, I., Ryan, G., Flanagan, S., & Gallagher, H. (2015). Dependence on Over the Counter (OTC) codeine containing analgesics: Treatment and recovery with buprenorphine naloxone. International Journal of Mental Health and Addiction. doi:10.1007/s11469-015-9618-2
- Wazaify, M., Hughes, C. M., & McElnay, J. C. (2006). The implementation of a harm minimisation model for the identification and treatment of over-the-counter drug misuse and abuse in community pharmacies in Northern Ireland. Patient Education and Counselling, 64(1), 136–141.
- Wright, J., Bond, C., Robertson, H., & Matheson, C. (2015). Changes in over-the-counter drug misuse over 20 years: Perceptions from Scottish pharmacists. Journal of Public Health, 1–7. doi:10.1093/pubmed/fdv169